D5446

7,8-Dihydroxyflavone hydrate

≥98% (HPLC)

• Formule empirique (notation de Hill): C₁₅H₁₀O₄ · xH₂O
• Numéro CAS: 38183-03-8
• Poids moléculaire : 254.24 (anhydrous basis)
• Numéro CE : 253-812-4
• Numéro MDL: MFCD00006836
• Code UNSPSC : 12352200
• ID de substance PubChem : 329798806
• Nomenclature NACRES : NA.77

Propriétés

• Niveau de qualité: 100
• Pureté: ≥98% (HPLC)
• Forme: solid
• Conditions de stockage: desiccated
• Solubilité: DMSO: 24 mg/mL
• Température de stockage: room temp
• Chaîne SMILES: Oc1ccc2C(=O)C=C(Oc2c1O)c3ccccc3
• InChI: 1S/C15H10O4/c16-11-7-6-10-12(17)8-13(19-15(10)14(11)18)9-4-2-1-3-5-9/h1-8,16,18H
• Clé InChI: COCYGNDCWFKTMF-UHFFFAOYSA-N

Description

Application

7,8-Dihydroxyflavone hydrate has been used as tropomyosin-receptor-kinase B (TrkB) agonist in mice and to inhibit TrkB for monitoring evoked excitatory postsynaptic currents (eEPSCs).

Actions biochimiques/physiologiques

7,8-Dihydroxyflavone (7,8-DHF) may be used to help identify and differentiate the physiological effects and cell signaling pathways mediated by TrkB activation, such as those involving, memory, vasorelaxation and hypertension. 7,8-DHF elicits protection in scopolamine induced Alzheimer-like pathologic dysfunction.

7,8-Dihydroxyflavone is a selective tyrosine kinase receptor B (TrkB) receptor agonist. It manifests all the therapeutic effects of brain-derived neurotrophic factor (BDNF)—such as protecting neurons from apoptosis, inhibiting kainic acid-induced toxicity, decreasing infarct volumes in stroke, and neuroprotecting in an animal model of Parkinson′s disease—without the poor pharmacokinetic profile of BDNF limiting its therapeutic potential.

Informations sur la sécurité

• Code de la classe de stockage: 11 - Combustible Solids
• Classe de danger pour l'eau (WGK): WGK 3
• Point d'éclair (°F): Not applicable
• Point d'éclair (°C): Not applicable